<VariationArchive RecordType="classified" VariationID="1714" VariationName="NM_000082.3:c.844_1122del" VariationType="Deletion" Accession="VCV000001714" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-01" DateCreated="2013-06-23" MostRecentSubmission="2013-06-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16753" VariationID="1714">
      <GeneList>
        <Gene Symbol="ERCC8" FullName="ERCC excision repair 8, CSA ubiquitin ligase complex subunit" GeneID="1161" HGNC_ID="HGNC:3439" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>5q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="60866454" stop="60945070" display_start="60866454" display_stop="60945070" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="60169658" stop="60240904" display_start="60169658" display_stop="60240904" Strand="-" />
          </Location>
          <OMIM>609412</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000082.3:c.844_1122del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q12</CytogeneticLocation>
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_466t1" sequenceAccession="LRG_466t1">
            <Expression>LRG_466t1:c.844_1122del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="609412.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The genomic location for allelic variant 609412.0001 will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the genomic basis for the skipping of exons 10 and 11.</Comment>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 609412.0001 as the 279 bp deletion.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000082.3:c.844_1122del AND Cockayne syndrome type 1" Accession="RCV000001784" Version="3">
        <ClassifiedConditionList TraitSetID="439">
          <ClassifiedCondition DB="MedGen" ID="C0751039">Cockayne syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-08-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-08-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-06-23" MostRecentSubmission="2013-06-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7664335</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="439" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1523" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome type A</ElementValue>
                <XRef ID="Cockayne+Syndrome/1701" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome classical</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome classic form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cockayne syndrome  type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cockayne syndrome type 1</ElementValue>
                <XRef ID="MONDO:0019569" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ERCC8</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CSA</ElementValue>
                <XRef Type="MIM" ID="216400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1415" />
                <XRef ID="1415" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cockayne syndrome (referred to as CS in this GeneReview) spans a continuous phenotypic spectrum that includes: CS type I, the "classic" or "moderate" form; CS type II, a more severe form with symptoms present at birth; this form overlaps with cerebrooculofacioskeletal (COFS) syndrome; CS type III, a milder and later-onset form; COFS syndrome, a fetal form of CS. CS type I is characterized by normal prenatal growth with the onset of growth and developmental abnormalities in the first two years. By the time the disease has become fully manifest, height, weight, and head circumference are far below the fifth percentile. Progressive impairment of vision, hearing, and central and peripheral nervous system function leads to severe disability; death typically occurs in the first or second decade. CS type II is characterized by growth failure at birth, with little or no postnatal neurologic development. Congenital cataracts or other structural anomalies of the eye may be present. Affected children have early postnatal contractures of the spine (kyphosis, scoliosis) and joints. Death usually occurs by age five years. CS type III is a phenotype in which major clinical features associated with CS only become apparent after age two years; growth and/or cognition exceeds the expectations for CS type I. COFS syndrome is characterized by very severe prenatal developmental anomalies (arthrogryposis and microphthalmia).</Attribute>
                <XRef ID="NBK1342" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301516</ID>
                <ID Source="BookShelf">NBK1342</ID>
              </Citation>
              <XRef ID="191" DB="Orphanet" />
              <XRef ID="90321" DB="Orphanet" />
              <XRef ID="C0751039" DB="MedGen" />
              <XRef ID="MONDO:0019569" DB="MONDO" />
              <XRef Type="MIM" ID="216400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21940" SubmissionDate="2013-06-20" DateLastUpdated="2013-06-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="609412.0001_COCKAYNE SYNDROME A" title="ERCC8, 279-BP DEL, 81-BP DEL_COCKAYNE SYNDROME A" />
        <ClinVarAccession Accession="SCV000021940" DateUpdated="2013-06-23" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-08-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs, born of consanguineous parents, with Cockayne syndrome A (216400), Henning et al. (1995) identified 2 deletions in the ERCC8 gene. One deletion removed 279 bp from the CKN1 coding region, starting at nucleotide 880 of their sequence and ending at nucleotide 1158. A second deletion of 81 bp in the CKN1 region started at nucleotide position 1078 and also ended at nucleotide position 1158. The fact that the deletions identified in both cDNAs from both sibs ended at the identical nucleotide positions strongly suggested to the authors that this nucleotide marks an exon/intron junction and the truncated cDNAs represent abnormally spliced products missing either 1 (81 bp) or 2 (279 bp) upstream exons. These abnormal splice products presumably derived from a homozygous mutation in a splice donor site. Neither deletion created a frameshift. Hence, the 2 abnormal transcripts potentially encode internally deleted proteins with predicted sizes of 303 and 369 amino acids.</Attribute>
              <Citation>
                <ID Source="PubMed">7664335</ID>
              </Citation>
              <XRef DB="OMIM" ID="216400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC8" />
          </GeneList>
          <Name>ERCC8, 279-BP DEL, 81-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">279-BP DEL, 81-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609412.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COCKAYNE SYNDROME A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="21940" TraitType="Disease" MappingType="Name" MappingValue="COCKAYNE SYNDROME A" MappingRef="Preferred">
        <MedGen CUI="C0751039" Name="Cockayne syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

